Sinopep-Allsino
688076.SSSinopep-Allsino Bio Pharmaceutical Co.,Ltd. Price (688076.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
214,389,612
(0.5656)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.Currency: CNY
| YEAR | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
8,777,246.00
+0% |
8,022,583.00
-9% |
228,867,458.00
+2,753% |
255,527,351.00
+12% |
371,530,570.00
+45% |
566,872,462.00
+53% |
643,869,464.00
+14% |
651,291,707.00
+1% |
1,026,346,449.00
+58% |
||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 425,909.00 | 593,704.00 | 7,530,295.00 | 13,630,935.00 | 87,824,664.00 | 101,991,860.00 | 173,251,896.00 | 237,156,213.00 | 284,874,798.00 | 276,321,614.00 | 444,267,009.00 | ||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
-425,909.00
+0% |
-593,704.00
+39% |
1,246,951.00
-310% |
-5,608,352.00
-550% |
141,042,794.00
-2,615% |
153,535,491.00
+9% |
198,278,674.00
+29% |
329,716,249.00
+66% |
358,994,666.00
+9% |
374,970,093.00
+4% |
582,079,440.00
+55% |
||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.14%) | (-0.70%) | (0.62%) | (0.60%) | (0.53%) | (0.58%) | (0.56%) | (0.58%) | (0.57%) | ||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 1,544,681.00 | 3,574,549.00 | 0.00 | 15,519,208.00 | 17,440,992.00 | 35,121,445.00 | 46,495,552.00 | 60,533,819.00 | 63,087,924.00 | 69,472,383.00 | 124,889,236.00 | ||||||||
| General and Administrative | 14,016,582.00 | 20,371,445.00 | 26,169,847.00 | 71,486,279.00 | 12,904,092.00 | 19,762,892.00 | 29,107,980.00 | 39,789,761.00 | 58,257,882.00 | 53,143,351.00 | 76,335,342.00 | ||||||||
| Selling, General & Admin... | 14,122,380.00 | 20,540,575.00 | 26,679,148.00 | 65,057,563.00 | 14,433,720.00 | 22,851,307.00 | 37,967,884.00 | 51,337,784.00 | 70,844,481.00 | 88,109,185.00 | 273,337,067.00 | ||||||||
| Selling & Marketing Exp... | 105,798.00 | 169,129.00 | 509,300.00 | 853,112.00 | 1,529,628.00 | 3,088,414.00 | 8,859,903.00 | 11,548,022.00 | 12,586,598.00 | 34,965,834.00 | 42,063,795.00 | ||||||||
| Depreciation and Amortiz... | 3,409,987.00 | 9,452,960.00 | 9,697,269.00 | 10,750,065.00 | 18,895,298.00 | 25,904,900.00 | 46,337,500.00 | 77,116,400.00 | 89,015,415.00 | 104,680,249.00 | 135,551,077.00 | ||||||||
| Other Expenses | 2,861,027.00 | 735,563.00 | 203,491.00 | -96,559.00 | 418,569.00 | -95,199.69 | 51,826,262.00 | 47,636,725.00 | 80,210,501.00 | 97,958,214.00 | 1,388,972.00 | ||||||||
| Total Operating Expenses | 14,122,380.00 | 20,540,575.00 | 26,679,148.00 | 65,154,123.00 | 73,278,274.00 | 111,997,599.00 | 136,289,699.00 | 159,508,328.00 | 214,142,907.00 | 255,539,783.00 | 399,615,275.00 | ||||||||
| Cost and Exponses | 14,122,380.00 | 20,540,575.00 | 34,209,444.00 | 78,785,056.00 | 161,102,939.00 | 213,989,460.00 | 309,541,595.00 | 396,664,542.00 | 499,017,706.00 | 531,861,398.00 | 843,882,284.00 | ||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-16,496,931.50
+0% |
-25,892,707.91
+57% |
-30,357,449.69
+17% |
-70,762,480.00
+133% |
56,595,259.00
-180% |
31,435,650.00
-44% |
67,809,228.00
+116% |
143,815,401.00
+112% |
128,313,239.00
-11% |
124,851,517.00
-3% |
189,665,794.00
+52% |
||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (-3.46%) | (-8.82%) | (0.25%) | (0.12%) | (0.18%) | (0.25%) | (0.20%) | (0.19%) | (0.18%) | ||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 0.00 | 0.00 | 4,544,316.00 | 192,772.00 | 440,939.00 | 600,030.00 | 736,821.00 | 5,294,340.00 | 8,576,656.00 | 5,871,166.00 | ||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 6,714,958.00 | 9,387,978.00 | 7,160,708.00 | 11,631,662.00 | 6,118,270.00 | 9,263,199.00 | 16,085,329.00 | ||||||||
| Total Other Income/Exp... | 2,861,027.00 | 735,563.00 | 203,491.00 | -4,035,019.00 | 418,569.00 | -95,200.00 | -14,396,248.00 | 2,745,641.00 | -2,581,892.00 | -1,693,288.00 | -16,538,921.00 | ||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -10,800,502.00 | -10,926,515.00 | -15,734,928.24 | -58,800,011.00 | 82,557,347.00 | 60,126,243.00 | 107,594,072.00 | 236,270,313.00 | 221,023,380.00 | 237,281,727.00 | 324,763,281.00 | ||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (-1.74%) | (-7.48%) | (0.38%) | (0.26%) | (0.29%) | (0.43%) | (0.36%) | (0.38%) | (0.32%) | ||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -13,635,903.59 | -25,157,144.65 | -30,153,958.24 | -74,797,496.00 | 57,013,828.00 | 31,340,450.00 | 53,412,980.00 | 146,561,042.00 | 125,731,347.00 | 123,158,229.00 | 173,126,873.00 | ||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (-3.44%) | (-9.32%) | (0.25%) | (0.12%) | (0.14%) | (0.26%) | (0.20%) | (0.19%) | (0.17%) | ||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 767,197.00 | 5,191,269.00 | 5,380,185.00 | 5.00 | 15,084,491.00 | -13,340,726.16 | 8,607,030.00 | 26,533,146.00 | 16,923,178.00 | 387,707.00 | 7,674,212.00 | ||||||||
| Net Income | |||||||||||||||||||
| Net Income | -13,635,903.59
+0% |
-25,157,144.65
+84% |
-30,153,958.24
+20% |
-74,797,496.00
+148% |
41,929,337.00
-156% |
43,908,449.00
+5% |
48,610,494.00
+11% |
123,441,585.00
+154% |
115,388,354.00
-7% |
129,106,565.00
+12% |
162,936,105.00
+26% |
||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (-3.44%) | (-9.32%) | (0.18%) | (0.17%) | (0.13%) | (0.22%) | (0.18%) | (0.20%) | (0.16%) | ||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.27 | -0.50 | -0.60 | -0.35 | 0.37 | 0.32 | 0.23 | 0.58 | 0.54 | 0.61 | 0.76 | ||||||||
| Diluted EPS | -0.27 | -0.50 | -0.60 | -0.35 | 0.37 | 0.32 | 0.23 | 0.58 | 0.54 | 0.61 | 0.76 | ||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 50,503,329.00 | 50,314,282.00 | 50,256,595.00 | 213,183,800.00 | 113,322,533.00 | 137,213,905.00 | 213,183,800.00 | 213,183,800.00 | 213,183,800.00 | 213,183,800.00 | 214,389,612.00 | ||||||||
| Diluted Share Outstanding | 50,503,329.00 | 50,314,289.00 | 50,256,597.00 | 213,183,800.00 | 113,322,533.00 | 137,213,905.00 | 213,183,800.00 | 213,183,800.00 | 213,183,800.00 | 213,183,800.00 | 214,389,612.00 | ||||||||